CL2008001552A1 - Compuestos derivados de piperidina-amida; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso de los compuestos para tratar la hiperglucemia, obesidad, hipertension, hiperlipidemia, aterosclerosis, fallo renal, diabetes. - Google Patents
Compuestos derivados de piperidina-amida; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso de los compuestos para tratar la hiperglucemia, obesidad, hipertension, hiperlipidemia, aterosclerosis, fallo renal, diabetes.Info
- Publication number
- CL2008001552A1 CL2008001552A1 CL2008001552A CL2008001552A CL2008001552A1 CL 2008001552 A1 CL2008001552 A1 CL 2008001552A1 CL 2008001552 A CL2008001552 A CL 2008001552A CL 2008001552 A CL2008001552 A CL 2008001552A CL 2008001552 A1 CL2008001552 A1 CL 2008001552A1
- Authority
- CL
- Chile
- Prior art keywords
- compounds
- hyperlipidemia
- atherosclerosis
- obesity
- hypertension
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4355—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Abstract
Compuestos derivados de piperidina-amida; procedimiento de preparación; composición farmacéutica que comprende a dicho compuesto; y uso de los compuestos para tratar la hiperglucemia, obesidad, hipertensión, hiperlipidemia, aterosclerosis, fallo renal, diabetes.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07109458 | 2007-06-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2008001552A1 true CL2008001552A1 (es) | 2009-05-22 |
Family
ID=39645621
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2008001552A CL2008001552A1 (es) | 2007-06-01 | 2008-05-29 | Compuestos derivados de piperidina-amida; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso de los compuestos para tratar la hiperglucemia, obesidad, hipertension, hiperlipidemia, aterosclerosis, fallo renal, diabetes. |
Country Status (17)
Country | Link |
---|---|
US (1) | US8039487B2 (es) |
EP (1) | EP2155738B1 (es) |
JP (1) | JP5220848B2 (es) |
KR (1) | KR101140520B1 (es) |
CN (1) | CN101679404B (es) |
AR (1) | AR066759A1 (es) |
AT (1) | ATE518857T1 (es) |
AU (1) | AU2008257693B2 (es) |
BR (1) | BRPI0811978A2 (es) |
CA (1) | CA2689383C (es) |
CL (1) | CL2008001552A1 (es) |
ES (1) | ES2369315T3 (es) |
IL (1) | IL202159A (es) |
MX (1) | MX2009013003A (es) |
PE (1) | PE20090320A1 (es) |
TW (1) | TW200901997A (es) |
WO (1) | WO2008145596A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101848908B (zh) * | 2007-09-06 | 2014-07-02 | 北京强新生物科技有限公司 | 激酶抑制剂的组合物及其在治疗癌症和其它与激酶相关的疾病中的用途 |
EP2567959B1 (en) | 2011-09-12 | 2014-04-16 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
KR102151288B1 (ko) | 2012-10-10 | 2020-09-03 | 이도르시아 파마슈티컬스 리미티드 | [오르토 바이 (헤테로 )아릴]-[2-(메타 바이 (헤테로 )아릴)-피롤리딘-1-일]-메타논 유도체인 오렉신 수용체 안타고니스트 |
CA2922703A1 (en) * | 2013-08-29 | 2015-03-05 | Baylor College Of Medicine | Compositions and methods for the treatment of metabolic and body weight related disorders |
CA3216365A1 (en) * | 2021-05-04 | 2022-11-10 | Venkateswara Rao BODDU | Diazepane derivatives, processes for their preparation, and uses thereof for the amelioration, prevention and/or treatment of mental and neurological diseases |
WO2023285349A1 (en) * | 2021-07-12 | 2023-01-19 | 2N Pharma Aps | Carnitine-palmitoyl-transferase-1 (cpt-1) inhibitors for use in a method of preventing or treating sepsis in a mammalian subject |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4055400A (en) * | 1999-04-02 | 2000-10-23 | Neurogen Corporation | Aryl and heteroaryl fused aminoalkyl-imidazole derivatives and their use as antidiabetics |
FR2865733B1 (fr) * | 2004-02-04 | 2007-10-12 | Merck Sante Sas | Derives de thiazolylimidazole, leurs procedes de preparation, les compositions pharmaceutiques qui les contiennent et leurs applications en medecine |
EP1604989A1 (en) * | 2004-06-08 | 2005-12-14 | Santhera Pharmaceuticals (Deutschland) Aktiengesellschaft | DPP-IV inhibitors |
WO2006131452A1 (en) * | 2005-06-06 | 2006-12-14 | F. Hoffmann-La Roche Ag | SULFONAMIDE DERIVATIVES USEFUL AS LIVER CARNITINE PALMITOYL TRANSFERASE (L-CPTl) INHIBITORS |
WO2007031429A1 (en) * | 2005-09-15 | 2007-03-22 | F. Hoffmann-La Roche Ag | Novel heterobicyclic derivatives useful as inhibitors of liver carnitine palmitoyl transferase |
PL1959951T3 (pl) | 2005-12-01 | 2010-06-30 | Hoffmann La Roche | Heteroarylo-podstawione pochodne piperydyny jako inhibitory l-cpt1 |
EA018920B1 (ru) * | 2008-05-05 | 2013-11-29 | Мерк Патент Гмбх | Производные тиазола в качестве ингибиторов 11-бета-гидроксистероид дегидрогеназы-1 |
DE102008029734A1 (de) * | 2008-06-23 | 2009-12-24 | Merck Patent Gmbh | Thiazolyl-piperidinderivate |
-
2008
- 2008-05-22 WO PCT/EP2008/056309 patent/WO2008145596A1/en active Application Filing
- 2008-05-22 KR KR1020097027484A patent/KR101140520B1/ko not_active IP Right Cessation
- 2008-05-22 MX MX2009013003A patent/MX2009013003A/es active IP Right Grant
- 2008-05-22 CN CN2008800167996A patent/CN101679404B/zh not_active Expired - Fee Related
- 2008-05-22 AU AU2008257693A patent/AU2008257693B2/en not_active Ceased
- 2008-05-22 ES ES08759910T patent/ES2369315T3/es active Active
- 2008-05-22 EP EP08759910A patent/EP2155738B1/en not_active Not-in-force
- 2008-05-22 AT AT08759910T patent/ATE518857T1/de active
- 2008-05-22 BR BRPI0811978-3A2A patent/BRPI0811978A2/pt not_active IP Right Cessation
- 2008-05-22 CA CA2689383A patent/CA2689383C/en not_active Expired - Fee Related
- 2008-05-22 JP JP2010509795A patent/JP5220848B2/ja not_active Expired - Fee Related
- 2008-05-23 US US12/125,976 patent/US8039487B2/en not_active Expired - Fee Related
- 2008-05-29 PE PE2008000919A patent/PE20090320A1/es not_active Application Discontinuation
- 2008-05-29 CL CL2008001552A patent/CL2008001552A1/es unknown
- 2008-05-29 AR ARP080102257A patent/AR066759A1/es not_active Application Discontinuation
- 2008-05-30 TW TW097120327A patent/TW200901997A/zh unknown
-
2009
- 2009-11-16 IL IL202159A patent/IL202159A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IL202159A (en) | 2013-07-31 |
KR20100017976A (ko) | 2010-02-16 |
JP2010529001A (ja) | 2010-08-26 |
US8039487B2 (en) | 2011-10-18 |
ATE518857T1 (de) | 2011-08-15 |
EP2155738A1 (en) | 2010-02-24 |
AU2008257693B2 (en) | 2011-01-27 |
CA2689383C (en) | 2013-10-08 |
CN101679404B (zh) | 2012-06-13 |
AU2008257693A1 (en) | 2008-12-04 |
CA2689383A1 (en) | 2008-12-04 |
BRPI0811978A2 (pt) | 2014-11-18 |
MX2009013003A (es) | 2010-01-20 |
EP2155738B1 (en) | 2011-08-03 |
TW200901997A (en) | 2009-01-16 |
ES2369315T3 (es) | 2011-11-29 |
PE20090320A1 (es) | 2009-03-19 |
IL202159A0 (en) | 2010-06-16 |
WO2008145596A1 (en) | 2008-12-04 |
AR066759A1 (es) | 2009-09-09 |
US20080300279A1 (en) | 2008-12-04 |
CN101679404A (zh) | 2010-03-24 |
KR101140520B1 (ko) | 2012-04-30 |
JP5220848B2 (ja) | 2013-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2008001049A1 (es) | Compuestos derivados de benzamidas sustituidas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la diabetes, intolerancia a la glucosa, dislipidemia, hipertension, obesidad. | |
CL2008002558A1 (es) | Compuestos derivados de catecolamina sustituidas, composicion farmaceutica, util para tratar parkinson, huntington, psicosis, impotencia e insuficiencia renal, entre otras enfermedades. | |
CL2008000316A1 (es) | Compuestos derivados de 2-metilsulfonil-1,2,3,4-tetrahidroisoquinolina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar la diabetes, hiperlipidemia, enfermedades cardiacas, artritis, osteoporosis, hipertension, catara | |
CL2008001552A1 (es) | Compuestos derivados de piperidina-amida; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso de los compuestos para tratar la hiperglucemia, obesidad, hipertension, hiperlipidemia, aterosclerosis, fallo renal, diabetes. | |
BRPI0922364A2 (pt) | Composto, composição farmacêutica e uso de um composto | |
CL2008000703A1 (es) | Compuestos derivados de pirimidinas sustituidas; procedimiento para la preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar transtornos hematologicos. | |
BRPI0809977A2 (pt) | Uso de um composto, compostos e composição farmacêutica que o contém | |
CL2007001915A1 (es) | Compuesto cristalino de 6-[4-cloro-3-(4-etoxibencil)fenil]tetrahidropiran-2,3,4,5,-tetraol; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y su uso para preparar un medicamento para tratar diabetes, dislipidemia, obesidad, entre otras. | |
BRPI0815709A2 (pt) | composro, composição farmacêutica, e, uso de um composto. | |
CL2008001201A1 (es) | Compuestos derivados de imidazol, triazol y/o piridina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar hipertension o insuficiencia cardiaca. | |
CL2008002997A1 (es) | Compuestos derivados de bifenilo, moduladores gpr40; proceso de preparacion de intermediarios; composicion farmaceutica que los comprende; y su uso para tratar diabetes tipo ii, obesidad, hiperlipoproteinemia, hperglucemia, intolerancia a la glucosa, enfermedad cardiovascular, ateroesclerosis, nefropatia, dermatopatia y cancer. | |
CL2007003154A1 (es) | Compuestos derivados de pirazolina; composicion farmaceutica que comprende a los compuestos; y uso para tratar afecciones cardiovasculares, renales, hepaticas y vasculares entre otras. | |
CL2007002107A1 (es) | Compuestos derivados de bencil piperidin-1-il amina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar hiperlipidemia, arterioesclerosis, ateroesclerosis, vasculopatia periferica, dislipidemia, entre otras enfermedades. | |
CL2008002076A1 (es) | Compuestos derivados de ariloxazoles sustituidos; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que los comprende; y su uso para tratar diabetes, sindrome metabolico, dislipidemias, entre otras enfermedades. | |
CL2010001530A1 (es) | Compuestos derivados de tiadiazoliloxifenilamidinas; su procedimiento de preparacion; agentes para combatir microorganismos indeseados que comprende a dichos compuestos; uso; procedimiento para combatir microorganismos indeseados; y compuestos intermediarios. | |
BRPI0716171A2 (pt) | composto, composiÇço farmacÊutica e uso de um composto. | |
BRPI0810696A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
CL2011000051A1 (es) | Compuestos derivados de piperidinilo, agonistas del receptor acoplado a la proteina g; composicion farmaceutica que los comprende; y su uso para la regulacion de la saciedad, tratar la obesidad, diabetes, sindrome metabolico, intolerancia ala glucosa, hiperlipidemias o hipertension, entre otras enfermedades. | |
CL2007003803A1 (es) | Compuestos derivados de sulfonamidas; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer, dislipidemia, diabetes, obesidad, infeccion. | |
CL2007001325A1 (es) | Compuestos derivados de biciclos, inhibidores de cept; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar hiperlipidemia, arterioesclerosis, entre otras enfermedades. | |
CL2007001753A1 (es) | Metodo para purificar rebaudiosida a sin refinar, mediante la combinacion con un solvente organico acuoso y posterior cristalizacion; y composicion farmaceutica que comprende los polimorfos. | |
BRPI0810161A2 (pt) | Composto, preparação farmacêutica, composição farmacêutica, e, uso de um composto | |
ECSP088800A (es) | Formulaciones de inhibidores de DPP IV | |
CL2008001372A1 (es) | Compuestos derivados de pirazol sustituidos con heteroarilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar trastornos hiperproliferativos y enfermedades relacionadas con angiogenesis. | |
CL2008001323A1 (es) | Compuestos derivados de triazolil aminopiridina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer. |